Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Baxter
Boehringer Ingelheim
Accenture
Chubb
Fuji
McKesson
Express Scripts
Dow

Generated: June 22, 2018

DrugPatentWatch Database Preview

CHILDREN'S ZYRTEC HIVES RELIEF Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Children's Zyrtec Hives Relief, and when can generic versions of Children's Zyrtec Hives Relief launch?

Children's Zyrtec Hives Relief is a drug marketed by J And J Consumer Inc and is included in two NDAs. There is one patent protecting this drug.

This drug has twenty-five patent family members in twenty countries.

The generic ingredient in CHILDREN'S ZYRTEC HIVES RELIEF is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and sixty-one suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
Summary for CHILDREN'S ZYRTEC HIVES RELIEF
Drug patent expirations by year for CHILDREN'S ZYRTEC HIVES RELIEF
Medical Subject Heading (MeSH) Categories for CHILDREN'S ZYRTEC HIVES RELIEF
Synonyms for CHILDREN'S ZYRTEC HIVES RELIEF
(+-)-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)acetic acid, dihydrochloride
(+) {2-[4-(alpha-phenyl-p-chlorobenzyl)-piperazine-1-yl] -ethoxy}-acetic acid dihydrochloride
(+/-)-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl] ethoxy]acetic acid, dihydrochloride
(+/-){2-[4-(alpha-phenyl-p-chlorobenzyl)-piperazin-1-yl]-ethoxy}-acetic acid dihydrochloride
(2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)acetic acid dihydrochloride
(R)-2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic acid dihydrochloride
(RS)-{2-[4-(alpha-phenyl-p-chlorobenzyl)-piperazin-1-yl]ethoxy }-acetic acid dihydrochloride
(RS)-{2-[4-(alpha-phenyl-p-chlorobenzyl)-piperazin-1-yl]ethoxy}-acetic acid dihydrochloride
[2-[4-[(4-Chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride
[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]aceticaciddihydrochloride
130018-82-5
2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic acid dihydrochloride
2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid dihydrichloride
2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid dihydrochloride
2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanoic acid dihydrochloride
2-[2-[4-[(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride
2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid dihydrochloride
2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride
83881-51-0 (Parent)
83881-52-1
881C510
A840675
AB0008484
AB1009381
AC-1600
AC1L1IJL
Acetic acid, (2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride
Acetic acid, (2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride, (+-)-
AK108356
AKOS000280979
AKOS016340521
Alercet
Alergex
Alerid
Alerlisin
Alertisin
Allergy relief
Alleroff
AN-14770
ANW-69482
API0001938
Apo-Cetirizine
AX8022801
BB_SC-2161
BG0436
C21H25ClN2O3.2HCl
C21H27Cl3N2O3
CAS-83881-52-1
CC0256
CCG-213404
Cetalerg
Ceterifug
Ceti TAD
Ceti-Puren
Cetiderm
Cetidura
Cetil von ct
CetiLich
Cetirigamma
Cetirizin AZU
Cetirizin Basics
Cetirizin dihydrochloride, >=98.0% (HPLC)
Cetirizine (dihydrochloride)
Cetirizine Di
Cetirizine diHCl
Cetirizine dihydrochloride
Cetirizine Dihydrochloride 1.0 mg/ml in Water (as free base)
Cetirizine dihydrochloride solution, 1.0 mg/mL in acetonitrile: water (9:1) (as free base), ampule of 1 mL, certified reference material
Cetirizine dihydrochloride, >=98% (HPLC)
Cetirizine dihydrochloride, European Pharmacopoeia (EP) Reference Standard
Cetirizine dihydrochloride, United States Pharmacopeia (USP) Reference Standard
Cetirizine for peak identification, European Pharmacopoeia (EP) Reference Standard
Cetirizine HCl
CETIRIZINE HYDROCHLORIDE
Cetirizine hydrochloride (JP17/USAN)
Cetirizine hydrochloride [USAN:USP]
Cetirizine hydrochloride [USAN]
Cetirizine Hydrochloride Allergy
Cetirizine Hydrochloride Hives
Cetirizine Hydrochloride, pharmaceutical secondary standard;traceable to USP, PhEur, BP
cetirizinedihydrochloride
Cetirlan
Cetriler
Cetrine
Cetzine
Cezin
CHEBI:3562
CHEMBL1607273
Children's Cetirizine hydrochloride allergy
Children's Cetirizine hydrochloride hives relief
Children's Zyrtec
Children's Zyrtec Allergy
CS-1798
CTK8C2999
D00664
DSSTox_CID_24268
DSSTox_GSID_44268
DSSTox_RID_80138
DTXSID2044268
Formistin
FT-0603000
HE180669
HE180670
HMS1569F07
HMS1922H04
HY-17042A
I06-0389
J10151
KS-000015AD
KS-1042
LP00362
LS-11411
MFCD00941428
MolPort-000-832-941
NCGC00016949-01
NCGC00095180-01
NCGC00095180-02
NCGC00255965-01
NCGC00261047-01
NCGC00263567-01
P 071
P-071
PGLIUCLTXOYQMV-UHFFFAOYSA-N
Prestwick_841
Reactine
Ressital
Riztec
RTR-026026
Ryzen
s1291
Salvalerg
SCHEMBL41107
Setiral
SPECTRUM1505371
ST077146
ST24039138
Stopaler
Sun mark all day allergy
Topcare all day allergy
Tox21_110704
Tox21_110704_1
Tox21_302261
Tox21_500362
Triz
UCB-P 071
Up and up all day allergy relief
Virdos
Voltric
Xero-sed
Zerviate
Zetir
Zirtin
Zyrtec
Zyrtec (TN)
Zyrtec Allergy
Zyrtec Hives Relief
Zyrtec-D
Zyrzine

US Patents and Regulatory Information for CHILDREN'S ZYRTEC HIVES RELIEF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc CHILDREN'S ZYRTEC HIVES RELIEF cetirizine hydrochloride SYRUP;ORAL 022155-001 Nov 16, 2007 OTC Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
J And J Consumer Inc CHILDREN'S ZYRTEC HIVES RELIEF cetirizine hydrochloride TABLET, CHEWABLE;ORAL 021621-005 Nov 16, 2007 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
J And J Consumer Inc CHILDREN'S ZYRTEC HIVES RELIEF cetirizine hydrochloride TABLET, CHEWABLE;ORAL 021621-006 Nov 16, 2007 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

Supplementary Protection Certificates for CHILDREN'S ZYRTEC HIVES RELIEF

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
01C/045 Belgium ➤ Try a Free Trial PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103
00085 Netherlands ➤ Try a Free Trial PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
QuintilesIMS
Chinese Patent Office
Johnson and Johnson
McKinsey
Express Scripts
Daiichi Sankyo
Citi
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.